Back to Journals » Patient Preference and Adherence » Volume 4

Patient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment options

Authors Nicola Scichilone, Adele Contino, Giovanni Battista Figlioli, et al

Published 3 February 2010 Volume 2010:4 Pages 17—23

DOI https://doi.org/10.2147/PPA.S5627

Review by Single-blind

Peer reviewer comments 2

Nicola Scichilone, Adele Contino, Giovanni Battista Figlioli, Giuseppe Paglino, Vincenzo Bellia

Dipartimento di Medicina, Pneumologia, Fisiologia e Nutrizione Umana (DIMPEFINU), University of Palermo, Palermo, Italy

Abstract: Asthma is a chronic inflammatory disorder of the airways that requires long-term treatment, the goal of which is to control clinical symptoms for extended periods with the least possible amount of drugs. International guidelines recommend the addition of an inhaled long-acting beta2-agonist (LABA) to a low- to medium-dose inhaled corticosteroid (ICS) when low doses of ICS fail to control asthma symptoms. The fixed combined administration of ICS/LABA improves patient compliance, reducing the risk of therapy discontinuation. The relative deposition pattern of the inhaled drug to the target site is the result of a complex interaction between the device used, the aerosol formulation and the patient’s adherence to therapy. Different inhalation devices have been introduced in clinical practice over time. The new hydrofluoroalkane (HFA) solution aerosols allow for the particle size to be modified, thus leading to deeper penetration of the medication into the lung. The Modulite® technology allows for the manipulation of inhaled HFA-based solution formulations, such as the fixed beclomethasone/formoterol combination, resulting in a uniform treatment of inflammation and bronchoconstriction. The success of any anti-asthmatic treatment depends on the choice of the correct device and the adherence to therapy.
Keywords: asthma, therapy, inhalers, compliance

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other articles by this author:

The use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics

Benfante A, Basile M, Battaglia S, Spatafora M, Scichilone N

Therapeutics and Clinical Risk Management 2016, 12:1553-1562

Published Date: 14 October 2016

Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations [Corrigendum]

Scichilone N, Spatafora M, Battaglia S, Arrigo R, Benfante A, Bellia V

Journal of Asthma and Allergy 2013, 6:67-68

Published Date: 24 May 2013

Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations

Scichilone N, Spatafora M, Battaglia S, Arrigo R, Benfante A, Bellia V

Journal of Asthma and Allergy 2013, 6:41-42

Published Date: 20 March 2013

Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations

Scichilone N, Spatafora M, Battaglia S, Arrigo R, Benfante A, Bellia V

Journal of Asthma and Allergy 2013, 6:11-21

Published Date: 9 January 2013

Anti-inflammatory effects of pre-seasonal Th1-adjuvant vaccine to Parietaria judaica in asthmatics

Scichilone N, Minaldi C, Santagata R, Battaglia S, Camarda G, Bellia V

Journal of Asthma and Allergy 2011, 4:19-25

Published Date: 25 March 2011

Readers of this article also read:

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010